Financial Summary (All financials)
In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
Revenues | 5,169.1 | 4,968.3 | 4,618.1 | 4,680.4 | 4,986.6 | 4,984.2 | 6,324.7 | 6,460.3 |
Revenue growth | 4.0% | 7.6% | -1.3% | -6.1% | 0.0% | -21.2% | -2.1% | 2330.9% |
Cost of goods sold | 1,068.1 | 1,200.2 | 1,169.8 | 1,094.9 | 1,101.7 | 983.6 | 2,574.1 | 2,871.7 |
Gross profit | 4,101.0 | 3,768.1 | 3,448.3 | 3,585.4 | 3,884.9 | 4,000.6 | 3,750.6 | 3,588.6 |
Gross margin | 79.3% | 75.8% | 74.7% | 76.6% | 77.9% | 80.3% | 59.3% | 55.5% |
Selling, general and administrative | | | | | | | | |
Sales and marketing | 881.5 | 1,080.7 | 1,084.4 | 1,083.9 | 1,101.6 | 1,122.2 | 1,264.0 | 1,245.4 |
Research and development | 1,055.5 | 1,177.9 | 1,156.4 | 957.6 | 885.8 | 919.4 | 1,028.7 | 1,210.2 |
General and administrative | 650.7 | 687.8 | 686.3 | 667.4 | 540.2 | 497.3 | 487.8 | 580.4 |
EBITA | 267.7 | 385.4 | 1,426.3 | 1,570.5 | 1,580.9 | 1,419.7 | 1,353.2 | 948.0 |
EBITA margin | 5.2% | 7.8% | 30.9% | 33.6% | 31.7% | 28.5% | 21.4% | 14.7% |
Amortization of intangibles | 100.2 | 136.7 | 131.5 | 96.5 | 105.4 | 118.0 | 127.0 | 184.0 |
EBIT | 167.5 | 248.6 | 1,294.8 | 1,474.0 | 1,475.5 | 1,301.7 | 1,226.2 | 764.0 |
EBIT margin | 3.2% | 5.0% | 28.0% | 31.5% | 29.6% | 26.1% | 19.4% | 11.8% |
Pre-tax income | -699.0 | -4,824.3 | 10,512.4 | 633.3 | 5,214.2 | 827.5 | 1,070.4 | 574.2 |
Income taxes | 126.2 | 89.6 | -4,038.1 | -153.4 | -1,940.0 | -241.8 | -221.5 | 0.0 |
Tax rate | | | | | | | | 0.0% |
Net income | -214.3 | -4,359.1 | 7,521.7 | 1,366.3 | 3,945.5 | 1,048.8 | 1,231.7 | 598.0 |
Net margin | -4.1% | -87.7% | 162.9% | 29.2% | 79.1% | 21.0% | 19.5% | 9.3% |
|
Diluted EPS | ($0.23) | ($4.64) | $7.49 | $1.28 | $3.28 | $0.82 | $0.90 | $0.42 |
Shares outstanding (diluted) | 949.8 | 939.1 | 1,004.1 | 1,070.8 | 1,202.9 | 1,282.3 | 1,364.6 | 1,415.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|